Cipla launches inhalable insulin for diabetes care
New Delhi, Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central…
Indian ‘Mantra’ for USA to make Robotic Surgery Affordable and Accessible there
MedTech Startup Files FDA 510(k) for Homegrown Surgical Robot SSIMantra New Delhi: Indian medtech company SS Innovations, maker of surgical robot SSIMantra has moved ahead to become emblem of affordability…
Centre draws a price line to curb cheap pharma imports
New Delhi: The Indian government has set a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers. The government imposed the…
47 Himachal-made medicines fail quality tests, companies asked to recall stock
These samples were part of a larger batch of 200 drugs tested nationwide that were found to be below standard, prompting the Central Drugs Standard Control Organisation (CDSCO) to issue…
Granules India arm gets 5 USFDA observations for Hyderabad facility
Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations at the Hyderabad facility of Granules Life Sciences, a wholly…
Drug regulator CDSCO flags 205 drug samples as not of standard quality in November
Central and state drug testing laboratories identified substandard and spurious medicines during routine nationwide surveillance India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged 205 drug…
Trump announces historic drug price cuts; Move likely to impact Indian pharma sector
The move aims to align American drug costs with the lowest international standards, a strategy that could significantly impact major generic suppliers like India Washington: In a major policy shift…
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District,…
Crackdown on Illegal Ayurvedic Syrup Factory: An Inside Look
In Madhya Pradesh’s Indore district, officials sealed an illegal Ayurvedic syrup factory located in a residential area. The factory, overseen by Surendra Singh, was found lacking a quality-test lab and…
Sun Pharma Baska facility gets OAI status from USFDA
Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration (USFDA) for Baska facility. The USFDA conducted an…
